Enzon Pharmaceuticals Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENZN | AMGN | BMY | GILD | MRNA |
| Company | Enzon Pharmaceuticals Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Moderna Inc |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.0780 | 273.45 | 47.39 | 67.47 | 107.43 |
| High | 0.0780 | 274.35 | 47.50 | 67.90 | 108.23 |
| Low | 0.0780 | 267.24 | 44.67 | 65.32 | 103.52 |
| Last | 0.0780 | 268.34 | 45.06 | 65.69 | 104.83 |
| Change | +0.0056 | -4.67 | -3.80 | -1.39 | -4.02 |
| % Change | +7.73% | -1.71% | -7.78% | -2.07% | -3.69% |
| Volume | 100 | 507,933 | 20,962,777 | 3,913,159 | 1,315,194 |
| 20-Day Average Volume | 17,455 | 2,082,630 | 11,553,728 | 6,282,957 | 3,060,273 |
| Previous Close | 0.0724 | 273.01 | 48.86 | 67.08 | 108.85 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0758 | 270.65 | 49.94 | 68.70 | 104.91 |
| 20-Day Raw Stochastic | 45.34% | 27.61% | 0.15% | 3.86% | 38.70% |
| 20-Day Relative Strength | 49.54% | 43.95% | 28.28% | 29.21% | 50.87% |
| Weighted Alpha | -71.72 | +8.56 | -34.78 | -23.11 | -13.55 |
| Today's Opinion | 72% Sell | 72% Sell | 88% Sell | 100% Sell | 88% Buy |
| Previous Opinion | 88% Sell | 40% Sell | 88% Sell | 100% Sell | 88% Buy |
| Last Month's Opinion | 88% Sell | 24% Buy | 8% Sell | 88% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -15.58% since 04/09/24 | +2.14% since 04/18/24 | -7.48% since 04/18/24 | -0.77% since 04/18/24 | +2.26% since 04/18/24 |
| Low | 0.0647 on 04/15/24 | 260.68 on 04/19/24 | 44.67 on 04/25/24 | 65.32 on 04/25/24 | 99.30 on 04/22/24 |
| High | 0.0953 on 04/10/24 | 274.86 on 04/24/24 | 49.56 on 04/22/24 | 67.78 on 04/25/24 | 111.29 on 04/24/24 |
| 1-Month | |||||
| %Chg | +11.43% since 03/22/24 | -4.43% since 03/25/24 | -14.48% since 03/25/24 | -9.55% since 03/25/24 | -5.50% since 03/25/24 |
| Low | 0.0600 on 04/01/24 | 260.68 on 04/19/24 | 44.67 on 04/25/24 | 65.32 on 04/25/24 | 97.00 on 04/03/24 |
| High | 0.0997 on 04/09/24 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 73.87 on 03/28/24 | 115.89 on 04/09/24 |
| 3-Month | |||||
| %Chg | -11.96% since 01/22/24 | -13.50% since 01/25/24 | -9.93% since 01/25/24 | -18.17% since 01/25/24 | +1.46% since 01/25/24 |
| Low | 0.0600 on 04/01/24 | 260.68 on 04/19/24 | 44.67 on 04/25/24 | 65.32 on 04/25/24 | 84.06 on 02/13/24 |
| High | 0.1058 on 01/26/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 80.51 on 01/26/24 | 115.89 on 04/09/24 |
| 6-Month | |||||
| %Chg | -44.92% since 10/23/23 | -1.39% since 10/25/23 | -21.07% since 10/25/23 | -16.25% since 10/25/23 | +35.89% since 10/25/23 |
| Low | 0.0600 on 04/01/24 | 249.70 on 10/31/23 | 44.67 on 04/25/24 | 65.32 on 04/25/24 | 62.55 on 11/02/23 |
| High | 0.1500 on 11/10/23 | 329.72 on 02/05/24 | 55.29 on 10/26/23 | 87.86 on 01/19/24 | 115.97 on 01/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,789 | 146,436,016 | 99,027,448 | 83,519,768 | 41,676,488 |
| Shares Outstanding, K | 74,220 | 536,376 | 2,026,759 | 1,245,077 | 382,880 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 6,848,000,000 |
| Annual Net Income | 1,370,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | -4,714,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 2,811,000,000 |
| Last Quarter Net Income | 670,000 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | 217,000,000 |
| 60-Month Beta | 0.33 | 0.58 | 0.39 | 0.19 | 1.62 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.01 on 03/20/24 | 4.71 on 02/06/24 | 1.70 on 02/02/24 | 1.72 on 02/06/24 | 0.55 on 02/22/24 |
| Latest Earnings Date | 05/03/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | 0.240 on 09/30/19 | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | 09/30/19 | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 7.24 | 14.67 | 6.53 | 9.97 | 0.00 |